What Are Cannabinoids

What Are Cannabinoids? The Active Molecules That Make Cannabis What It Is

Your body already produces its own cannabinoids. That single fact reshapes everything most people think they know about why cannabis works — it isn't forcing a foreign reaction; it's speaking a chemical language your cells already understand. With over 100 distinct cannabinoids identified in the cannabis plant, and a dedicated receptor system built right into your nervous and immune tissue, the relationship between cannabis and the human body is far more precise and far more fascinating than any "gets you high" summary gives it credit for.

Cannabinoids Defined: More Than Just THC and CBD

Cannabinoids are naturally occurring compounds produced in the resin glands — the trichomes — of the cannabis plant. They are the pharmacologically active constituents responsible for every effect cannabis has on the human body, from the euphoric rush of a high-THC sativa to the clear-headed calm of a CBD-dominant cultivar. Think of them as the plant's chemical signature: the reason two strains can look almost identical in the garden yet produce completely different experiences in the body.

Scientists have identified more than 100 individual cannabinoids in cannabis, but not all appear in meaningful concentrations. The ones that do — THC, CBD, CBG, CBN, and CBC being the most studied — each carry distinct pharmacological profiles. THC and CBD get the headlines, but the supporting cast matters enormously, particularly because of a phenomenon called the entourage effect: the well-supported principle that cannabinoids work synergistically, producing better outcomes together than any single compound delivers in isolation.

You'll encounter cannabinoids in every product format legal under Canada's Cannabis Act — dried flower, full-spectrum concentrates, regulated edibles, sublingual oils, and topicals. The delivery method changes the onset time, duration, and intensity of effects, but the cannabinoids themselves remain the engine driving it all.

How Cannabinoids Work: The Endocannabinoid System

The endocannabinoid system (ECS) is a biological network of receptors, endogenous ligands, and metabolic enzymes distributed throughout the brain, central nervous system, and peripheral tissues. Its primary function is homeostasis — keeping physiological processes like mood, appetite, memory, immune response, pain perception, and sleep in dynamic balance. Your body maintains this system whether you ever consume cannabis or not.

When you do consume cannabis, phytocannabinoids from the plant interact with two primary receptor classes:

CB1 receptors — concentrated in the brain, spinal cord, and central nervous system; primarily responsible for the psychoactive effects of THC, as well as modulation of pain, mood, and appetite.
CB2 receptors — found mainly in immune tissue, the spleen, and peripheral organs; associated with anti-inflammatory responses and immune regulation rather than intoxication.

Different cannabinoids engage these receptors in fundamentally different ways. THC is a direct agonist at CB1 — it binds tightly and activates the receptor, producing the classic high. CBD, by contrast, has low binding affinity for both CB1 and CB2 and instead modulates the ECS indirectly: inhibiting the enzyme that breaks down the endocannabinoid anandamide, antagonising certain receptor subtypes, and influencing serotonin signalling. The result is measurable physiological effect without intoxication. CBG, CBN, and others each have their own receptor targets and indirect mechanisms, which is why the full-spectrum profile of a cultivar matters as much as its headline THC percentage.

The practical takeaway for growers and buyers is this: chasing a single number on a lab report — say, 28% THC — tells you less about a cultivar's actual experience than understanding its full cannabinoid and terpene profile working together.

Types of Cannabinoids: Plant-Derived, Endogenous, and Synthetic

Not every cannabinoid comes from a cannabis plant, and not every lab-made cannabinoid is created equal. Understanding the three categories helps you make smarter decisions about what you grow and what you consume.

Phytocannabinoids

These are the cannabinoids native to the cannabis plant, biosynthesised in the trichome heads from a common precursor, cannabigerolic acid (CBGA). They include:

THC (tetrahydrocannabinol) — the primary psychoactive compound; responsible for euphoria, appetite stimulation, altered sensory perception, and potent analgesic effects.
CBD (cannabidiol) — non-intoxicating; modulates anxiety, inflammation, and neuroprotection through indirect ECS pathways and serotonin receptor interaction.
CBG (cannabigerol) — the "mother cannabinoid" from which all others are enzymatically derived; present in highest concentrations during early vegetative growth before it converts to THC and CBD. Research indicates potential for anti-inflammatory, neuroprotective, and tumour-suppressing activity.
CBN (cannabinol) — produced by the oxidative degradation of THC; found in aged or improperly cured cannabis. Associated with sedative properties and being studied for antibacterial applications.
CBC (cannabichromene) — non-intoxicating; emerging research suggests roles in mood regulation and neurogenesis.

Endocannabinoids

Your body synthesises its own cannabinoids on demand. The two best characterised are anandamide — nicknamed the "bliss molecule" for its role in pleasure, motivation, and pain modulation — and 2-arachidonoylglycerol (2-AG), which regulates immune function, nociception, and energy metabolism. The existence of these endogenous molecules is precisely why the plant's phytocannabinoids integrate so smoothly into human physiology: the receptors were built for molecules very much like them.

Synthetic Cannabinoids

Laboratory-synthesised cannabinoids serve legitimate roles in pharmaceutical research — nabilone, a synthetic THC analogue, is an approved anti-nausea medication in Canada. However, illicitly produced synthetic cannabinoids sold under names like "Spice" or "K2" are chemically unpredictable, often far more potent at CB1 than natural THC, and carry serious risks including psychosis and cardiovascular events. The Cannabis Act framework exists specifically to move Canadians away from these unregulated products and toward regulated, lab-tested cannabis with known cannabinoid profiles. When in doubt, source from a licensed producer or a seed bank like Pacific Seed Bank whose genetics are backed by rigorous breeder documentation.

Cannabinoids vs. THC vs. CBD: Getting the Vocabulary Right

The three terms are not interchangeable, though you'll hear them treated that way constantly.

Cannabinoids is the umbrella category — the full family of over 100 compounds. THC and CBD are individual members of that family, the two that occur in the highest concentrations in most commercially bred cultivars and therefore attract the most scientific and consumer attention. Knowing the difference matters practically: a cultivar marketed simply as "high cannabinoid" tells you almost nothing, while one labelled with a specific THC:CBD ratio gives you a functional roadmap of the experience it's likely to produce.

Compare the two stars directly:

THC binds directly to CB1 receptors, producing psychoactivity, appetite stimulation, euphoria, and dose-dependent impairment. Onset and intensity vary by consumption method and individual tolerance.
CBD does not bind meaningfully to CB1, produces no intoxication, and is widely used for its anxiolytic, anti-inflammatory, and anti-epileptic properties. It can also attenuate some of THC's less desirable effects — anxiety and paranoia at high doses — by modulating CB1 receptor activity indirectly.

The practical upshot: a 1:1 THC:CBD cultivar will feel very different from a 20:1 THC-dominant one, even at identical total cannabinoid percentages. CBD-rich feminised options like CBD Therapy Feminized — carrying a remarkable 1:20 THC to CBD ratio with sweet, spicy aromatics — and the sativa-leaning CBD PH Haze Feminized, with its fruit-and-spice nose and clear-headed medicinal profile, are exactly the kind of cultivars that illustrate how powerfully ratio shapes outcome.

The Supporting Cast: CBN, CBG, and Why Minor Cannabinoids Matter

THC and CBD earned their fame, but the rest of the cannabinoid spectrum is where the next decade of cannabis science is heading. Here is what we currently know about the most significant minor cannabinoids — and why growers should be paying attention.

CBN — Cannabinol

CBN was among the first cannabinoids isolated by chemists, discovered alongside THC and CBD in early structural analyses of cannabis resin. It does not occur in fresh plant material at meaningful concentrations; it is a by-product of THC oxidation, which means it accumulates as cannabis ages or is exposed to heat and light without adequate curing protocols. Growers who rush the cure or store dried flower improperly will inadvertently produce CBN-heavy product. The compound is considered sedating and is under active investigation for antibacterial properties — an area of genuine pharmaceutical interest given the global antibiotic resistance crisis.

CBG — Cannabigerol

Without CBG, there would be no THC, no CBD, and no CBC. CBGA (the acid form of CBG) is the biosynthetic precursor from which all other major phytocannabinoids are derived via enzymatic action in the trichome. This is why CBG concentrations are highest in young plants during the vegetative and early flowering stages, then decline as the plant converts it into THC and CBD. Breeders have developed CBG-dominant cultivars by selecting for genetic mutations that impair downstream conversion enzymes — a fascinating demonstration of how cannabinoid profiles are genetically determined, not environmentally induced.

The pharmacological profile of CBG is remarkable. Research attributes to it appetite stimulation, promotion of bone and neural cell growth, anti-seizure and sedating properties, anti-inflammatory action, and suppression of tumour cell proliferation — making it one of the most pharmacologically rich cannabinoids currently under the scientific microscope. Studies examining CBG's effects on inflammatory bowel disease and bladder dysfunction are particularly promising.

CBC — Cannabichromene

CBC doesn't bind strongly to CB1 or CB2 but instead interacts with other receptor targets including TRPV1 (the vanilloid receptor involved in pain and inflammation). Early research suggests CBC may contribute to neurogenesis — the growth of new brain cells — and amplify the antidepressant effects of anandamide. It's non-intoxicating and appears frequently in full-spectrum extracts where the entourage effect is the design goal.

Boosting Cannabinoids in Your Home-Grown Cannabis

Every serious grower eventually confronts this reality: you cannot coax a strain beyond its genetic ceiling for cannabinoid production. A cannabis plant expresses cannabinoids up to a genetically encoded upper limit, and no amount of premium nutrient formulation, UV light supplementation, or stress training will push THC beyond what the genome permits. Environmental optimisation — dialling in vapour pressure deficit (VPD) between 0.8 and 1.2 kPa during flowering, maintaining phosphorus and potassium ratios that support resin synthesis, timing harvest precisely by trichome colour rather than calendar — will get you to that ceiling reliably, but the ceiling itself is set at germination.

This is why genetics are the first decision, not an afterthought.

Start with cultivars bred specifically for the cannabinoid profile you're targeting, sourced from breeders who document their work. Below are some standout options across the cannabinoid spectrum that Canadian home growers under the Cannabis Act (up to four plants per household) will find worth considering:

High-THC, balanced sativa buzz: Romulan Haze Feminized — a sativa-dominant photoperiod cultivar delivering euphoric, focused elevation without the ceiling-crash of pure indicas.
High-THC creative hybrid: Red Bullz Feminized — an indica-leaning hybrid whose cerebral, artistically unlocking sativa expression makes it a cultivar that punches above its genetic weight class.
Three-way THC powerhouse: 3 Kings Auto Feminized — a lineage of Headband, Sour Diesel, and OG Kush producing earthy, piney flavour and a bright, clear-headed elevation that growers treasure for its consistency.
Relaxing high-CBD medicinal: CBD Therapy Feminized — that extraordinary 1:20 THC:CBD ratio in a complex, sweet-and-spicy package that is genuinely therapeutic without sedation.
Indica body sedation, fast autoflower: Hash Plant Auto — a sturdy, beginner-friendly autoflowering cultivar with potent resin production and deep physical relief.
Nighttime indica escape: Purple Alien OG Feminized — or its autoflowering sibling, Purple Alien OG, an indica-dominant cultivar built for deep relaxation and restful sleep.
Legendary body-lock Kush: Tahoe OG Kush Auto Feminized — the classic couch-lock cultivar, lazy and body-heavy, with the kind of resin density that rewards patient, thorough curing.
Classic sativa THC expression: Purple Haze Feminized — the sativa-dominant Hendrix-era classic, delivering outstanding genetics and uplifting, creative cerebral effects.
Sweet indica autoflower: Sirius Black Auto Feminized — aromatically rich with grape and berry notes, a smooth, floral exhale, and a deeply relaxing cannabinoid profile perfect for end-of-day unwinding.
OG indica with anti-inflammatory depth: Red Eye OG Feminized — a high-THC indica delivering soothing, full-body relaxation alongside the kind of CB2-mediated anti-inflammatory activity that makes it a grower favourite for personal medicinal use.
Dessert-flavoured balanced auto: Mint Chocolate Chip Auto Feminized — a late-afternoon treat that opens with creative uplift and closes with a warm, relaxing body stone, demonstrating how a well-balanced cannabinoid ratio can deliver a layered, evolving experience in a single session.
Sativa-leaning CBD medicinal: CBD PH Haze Feminized — fruit-and-spice aromatics with a happiness-forward, relaxing effect profile; among the best sativa-dominant CBD cultivars available to Canadian growers.

Once you've selected high-quality genetics, your cultivation practices determine whether you reach the plant's full cannabinoid potential. Manage VPD carefully through flowering, push phosphorus and potassium in the mid-to-late bloom phase without over-feeding nitrogen, and harvest based on trichome colour — cloudy to amber — rather than the breeder's estimated flowering day. Cure slowly at 60–65% relative humidity for a minimum of three weeks. Cannabinoid and terpene preservation during cure is as significant as any variable in the grow room.

Choosing Your Cannabinoid Profile: A Practical Framework

Understanding cannabinoids academically is one thing. Translating that knowledge into a purchasing or cultivation decision is where it becomes genuinely useful. Consider your goals first, then match genetics to those goals:

Seeking strong psychoactivity and creative stimulation? Prioritise high-THC, sativa-leaning cultivars with terpene profiles rich in limonene and terpinolene.
Seeking relaxation and physical relief without heavy intoxication? Look for balanced or CBD-dominant cultivars, or indica-dominant THC strains with myrcene-forward terpene profiles at moderate doses.
Seeking medicinal efficacy with minimal impairment? High-CBD, low-THC feminised strains — particularly those with 10:1 or 20:1 CBD:THC ratios — are where breeders have made remarkable strides over the past decade.
Seeking the full entourage effect? Choose full-spectrum, multi-cannabinoid cultivars and avoid products processed to isolate a single cannabinoid. Whole-plant expression, guided by expert genetics, remains the most sophisticated cannabinoid delivery system available.

Canada's regulatory environment under the Cannabis Act — with its emphasis on lab testing, accurate labelling, and licensed production — gives Canadian consumers and home growers something genuinely valuable: reliable information about what's actually in the plant. Use it. Read the cannabinoid panel on your seeds, your flower, and your extracts, and let that data guide your choices.

The science of cannabinoids is still young. CBG's tumour-fighting potential, CBC's neurogenic properties, CBN's antibacterial action — these are areas where the next ten years of research will dramatically expand what we know. But you don't need to wait for the science to mature to make excellent decisions today. Shop Marijuana Seeds at Pacific Seed Bank to explore genetics across the full cannabinoid spectrum, and browse the complete strain catalogue to find the profile that matches exactly what you're trying to grow and experience. Start with superior genetics, optimise your environment, and let the plant's own biochemistry do the rest.